{"version":"1.2.0","chapters":[{"startTime":0,"endTime":299},{"startTime":299,"endTime":510,"title":"Alpha-Synuclein Phosphorylation and Its Physiological Role"},{"startTime":510,"endTime":550,"title":"Implications of Phosphorylation in Disease and Therapy"},{"startTime":550,"endTime":708,"title":"Mitochondrial Pathways in Parkinson's Disease"},{"startTime":708,"endTime":827,"title":"Complex I Dysfunction and Parkinson's Phenotypes"},{"startTime":827,"endTime":1027,"title":"Biomarkers for Early Detection and Stratification"},{"startTime":1027,"endTime":1430,"title":"Future Directions in Neurodegenerative Research"},{"startTime":1430,"endTime":1529,"title":"Sex Differences and Hormonal Influences in Disease"},{"startTime":1529,"endTime":1852,"title":"Patient and Caregiver Perspectives in Research"},{"startTime":1852,"endTime":2046,"title":"Open Data, Collaboration, and Sharing in Science"},{"startTime":2046,"endTime":2354,"title":"The Role of Infection and Neuroinflammation"},{"startTime":2354,"endTime":2475,"title":"Alpha-Synuclein and Mitochondria"},{"startTime":2475,"endTime":2584,"title":"Vesper's Small Molecules and Clinical Trials"},{"startTime":2584,"endTime":2851.03,"title":"Concluding Remarks and Future Outlook"}]}